1. Home
  2. PRZO vs ONCO Comparison

PRZO vs ONCO Comparison

Compare PRZO & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRZO
  • ONCO
  • Stock Information
  • Founded
  • PRZO 2014
  • ONCO 2018
  • Country
  • PRZO Israel
  • ONCO United States
  • Employees
  • PRZO N/A
  • ONCO N/A
  • Industry
  • PRZO
  • ONCO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRZO
  • ONCO Health Care
  • Exchange
  • PRZO Nasdaq
  • ONCO Nasdaq
  • Market Cap
  • PRZO 16.9M
  • ONCO 9.4M
  • IPO Year
  • PRZO 2023
  • ONCO 2022
  • Fundamental
  • Price
  • PRZO $1.38
  • ONCO $0.54
  • Analyst Decision
  • PRZO
  • ONCO
  • Analyst Count
  • PRZO 0
  • ONCO 0
  • Target Price
  • PRZO N/A
  • ONCO N/A
  • AVG Volume (30 Days)
  • PRZO 4.1M
  • ONCO 9.9M
  • Earning Date
  • PRZO 03-26-2025
  • ONCO 04-10-2025
  • Dividend Yield
  • PRZO N/A
  • ONCO N/A
  • EPS Growth
  • PRZO N/A
  • ONCO N/A
  • EPS
  • PRZO N/A
  • ONCO N/A
  • Revenue
  • PRZO $558,382.00
  • ONCO $1,870,605.00
  • Revenue This Year
  • PRZO N/A
  • ONCO N/A
  • Revenue Next Year
  • PRZO N/A
  • ONCO N/A
  • P/E Ratio
  • PRZO N/A
  • ONCO N/A
  • Revenue Growth
  • PRZO N/A
  • ONCO N/A
  • 52 Week Low
  • PRZO $0.49
  • ONCO $0.32
  • 52 Week High
  • PRZO $3.16
  • ONCO $21.40
  • Technical
  • Relative Strength Index (RSI)
  • PRZO 38.09
  • ONCO 43.56
  • Support Level
  • PRZO $1.15
  • ONCO $0.58
  • Resistance Level
  • PRZO $1.77
  • ONCO $0.70
  • Average True Range (ATR)
  • PRZO 0.14
  • ONCO 0.10
  • MACD
  • PRZO -0.05
  • ONCO 0.01
  • Stochastic Oscillator
  • PRZO 29.37
  • ONCO 5.94

About PRZO ParaZero Technologies Ltd.

ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the comapany applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

Share on Social Networks: